Zevra Therapeutics, Inc. (ZVRA)
NASDAQ · Healthcare
Zevra Therapeutics, Inc. Net Income 2013–2025
Zevra Therapeutics, Inc. annual/quarterly net income history and growth rate from 2013 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Zevra Therapeutics, Inc. net income for the quarter ending March 31, 2026 was 37.9 M, a 1322.65% decrease year-over-year.
- Zevra Therapeutics, Inc. net income for the twelve months ending March 31, 2026 was 109.0 M, a 235.96% decrease year-over-year.
- Zevra Therapeutics, Inc. annual net income for 2025 was 83.2 M, a 178.88% decrease from 2024.
- Zevra Therapeutics, Inc. annual net income for 2024 was -105.5 M, a 129.13% increase from 2023.
- Zevra Therapeutics, Inc. annual net income for 2023 was -46.0 M, a 72.00% increase from 2022.
- Zevra Therapeutics, Inc. annual net income for 2022 was -26.8 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Zevra Therapeutics, Inc. Net Income — FAQ
Zevra Therapeutics, Inc. (ZVRA) net income over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
What is Zevra Therapeutics, Inc.'s net income?
Zevra Therapeutics, Inc. (ZVRA) reported net income of $83M for fiscal 2025.
Where can I see ZVRA's net income history?
The chart and table above show Zevra Therapeutics, Inc.'s net income by year and by quarter, including the growth rate.